|
|
Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy |
| 4UH3TR003271-03 |
|
NCATS |
2022 |
|
|
Optimizing Muscular Dystrophy Clinical Trial Designs using Modeling and Simulation |
| 5R21TR004006-02 |
|
NCATS |
2022 |
|
|
Integrated Microphysiological System of Cerebral Organoid and Blood Vessel for Disease Modeling and Neuropsychiatric Drug screening |
| 5UH3TR002151-05 |
|
NCATS |
2022 |
|
|
Building a two-way communication system: Bio-orthogonal superhydrophobic nanoparticles for controlled stimulation and real-time sensing of neurotransmitters |
| 1DP2GM150018-01 |
|
NIGMS |
2022 |
|
|
Decode Mitochondrial Morphology Dynamics to Predict Cell Fate Decisions |
| 1DP2GM150022-01 |
|
NIGMS |
2022 |
|
|
Epigenetic and transcriptional consequences of Intellectual Disability-associated mutations in the histone lysine demethylase KDM5. |
| 1F31GM146347-01 |
|
NIGMS |
2022 |
|
|
Dynamic interplay of eukaryotic translation and mRNA decay |
| 1K99GM140209-01A1 |
|
NIGMS |
2022 |
|
|
Isoform expression and post-transcriptional regulation of centrosomal plp mRNA |
| 1K99GM143517-01A1 |
|
NIGMS |
2022 |
|
|
Uncovering novel players in nucleolar organization and function |
| 1R01GM145744-01 |
|
NIGMS |
2022 |
|
|
Scramblases for protein glycosylation |
| 1R01GM146011-01 |
|
NIGMS |
2022 |
